Cirrhosis Survival Spiked
Good news for cirrhosis patients: Survival may be much more common than it once was.
This Rx Combo Fought Hep C
Hepatitis C patients may soon have another medication option.
This Hep C Rx Combo May Be Quicker Cure
For people with hepatitis C, three isn't a crowd. These patients got well much faster with the addition of a third medication.
Cirrhosis: Usually Preventable but Common
Cirrhosis of the liver may usually be preventable, but it may be more common than previously thought. Fortunately, patients can take simple steps to keep their livers in tip-top shape.
Gilead Announces Harvoni Results from Phase 2 and Phase 3 Studies
Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from several Phase 2 and Phase 3 studies evaluating investigational uses of Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) for the treatment of chronic hepatitis C virus (HCV) infection in patients with limited or no treatment options, including patients with decompensated cirrhosis, patients with HCV recurrence following a liver transplant and patients who failed previous treatment with other direct acting antivirals.
Becoming Hepatitis Aware
The liver may not be something we think about on a daily basis, but it's one of our vital organs. Hepatitis is a group of conditions that can harm the liver, and much like the organ itself, these conditions may be overlooked.
With Hep C, Alcohol is a No Go
For healthy people, a drink or two can be okay. But for people with hepatitis C liver infections, a drink or two a day might be very dangerous.
Is Hep C Retreatment Worth It?
Hepatitis C is an infection that can lead to serious liver problems. As such, treatment is required to protect patients from these complications. Unfortunately, one treatment does not appear to do much good.
Get Vaccinated, Stop the Spread of Hep B
There are a great deal of complications associated with diabetes. In order to prevent these complications, patients have to take special care of themselves, whether that means eating healthier or getting vaccinated.
Help is Here, but You Aren't Eligible
Lack of health insurance coverage may affect hepatitis C patients' access to current antiviral treatments, according to a new study.